Clinical aspects and prospects of using DPP-4 inhibitors

Clinical aspects and prospects of using DPP-4 inhibitors

Type 2 diabetes mellitus is a serious disease associated with the development of severe complications. Recent advances in diabetology are related to hormone therapy. The mechanism of action of DPP-4 inhibitors is discussed. The results of clinical studies of the efficacy and safety of gosogliptine a...

Full description

Bibliographic Details
Main Author: E. V. Biryukova
Format: Article
Language:Russian
Published: Remedium Group LLC 2019-08-01
Series:Медицинский совет
Subjects:
type 2 diabetes mellitus
vascular complications
sugar-reducing therapy
dpp-4 inhibitors
gosogliptine
Online Access:https://www.med-sovet.pro/jour/article/view/3111
id doaj-a1c25880fedd4af7877f06b12d25c7ea
record_format Article
spelling doaj-a1c25880fedd4af7877f06b12d25c7ea2021-07-28T13:29:42ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-08-0104242910.21518/2079-701X-2019-4-24-293019Clinical aspects and prospects of using DPP-4 inhibitorsE. V. Biryukova0Federal State Budgetary Educational Institution of the Higher Education «Moscow State University of Medicine and Dentistry named after A.I. Yevdokimov» of the Ministry of Healthcare of the Russian FederationType 2 diabetes mellitus is a serious disease associated with the development of severe complications. Recent advances in diabetology are related to hormone therapy. The mechanism of action of DPP-4 inhibitors is discussed. The results of clinical studies of the efficacy and safety of gosogliptine are presented.https://www.med-sovet.pro/jour/article/view/3111type 2 diabetes mellitusvascular complicationssugar-reducing therapydpp-4 inhibitorsgosogliptine
collection DOAJ
language Russian
format Article
sources DOAJ
author E. V. Biryukova
spellingShingle E. V. Biryukova
Clinical aspects and prospects of using DPP-4 inhibitors
Медицинский совет
type 2 diabetes mellitus
vascular complications
sugar-reducing therapy
dpp-4 inhibitors
gosogliptine
author_facet E. V. Biryukova
author_sort E. V. Biryukova
title Clinical aspects and prospects of using DPP-4 inhibitors
title_short Clinical aspects and prospects of using DPP-4 inhibitors
title_full Clinical aspects and prospects of using DPP-4 inhibitors
title_fullStr Clinical aspects and prospects of using DPP-4 inhibitors
title_full_unstemmed Clinical aspects and prospects of using DPP-4 inhibitors
title_sort clinical aspects and prospects of using dpp-4 inhibitors
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2019-08-01
description Type 2 diabetes mellitus is a serious disease associated with the development of severe complications. Recent advances in diabetology are related to hormone therapy. The mechanism of action of DPP-4 inhibitors is discussed. The results of clinical studies of the efficacy and safety of gosogliptine are presented.
topic type 2 diabetes mellitus
vascular complications
sugar-reducing therapy
dpp-4 inhibitors
gosogliptine
url https://www.med-sovet.pro/jour/article/view/3111
work_keys_str_mv AT evbiryukova clinicalaspectsandprospectsofusingdpp4inhibitors
_version_ 1721273736133345280

Similar Items